Acne clinical trials

Medical name: Acne vulgaris · Skin

By location or age: Children and teens · California · Florida · Kentucky · Michigan

102 trials are recruiting, according to ClinicalTrials.gov.

Showing 100 of 102, newest first. Checked against the registry on 22 November 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.

Recruiting · Phase 4 · Listed on Beacon

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

Ages 9 Years to 11 Years · 15 sites · Bausch Health Americas, Inc.

Details and how to check if you qualify · NCT07524946 on ClinicalTrials.gov

Not yet recruiting · Early Phase 1

Role of Akkermansia Muciniphila in Acne Vulgaris

Ages 18 Years to 45 Years · 0 sites · Medical University of South Carolina

NCT06992154 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Active Versus Vehicle Home Care During PRX S Treatment for Mild-to-Moderate Facial Acne

Ages 18 Years to 60 Years · 2 sites · Medical University of Silesia

NCT07944274 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Clinical Outcomes of PRX S With Standardized Home Care in Mild-to-Moderate Facial Acne.

Ages 18 Years to 60 Years · 2 sites · Medical University of Silesia

NCT07941440 on ClinicalTrials.gov

Not yet recruiting · Phase 3

Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.

Ages 18 Years to 45 Years · 1 site · Cairo University

NCT07919886 on ClinicalTrials.gov

Recruiting · Not applicable

Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation

Ages 18 Years to no maximum · 1 site · Weill Medical College of Cornell University

NCT07896486 on ClinicalTrials.gov

Not yet recruiting · Not applicable

A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected Skin

Ages 18 Years to 65 Years · 1 site · BrocShot Inc

NCT07946250 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne

Ages 15 Years to no maximum · 1 site · Allied Hospital Faisalabad

NCT07881315 on ClinicalTrials.gov

Recruiting · Phase 2

Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity

Ages 18 Years to no maximum · 1 site · Regeneron Pharmaceuticals

NCT07830329 on ClinicalTrials.gov

Enrolling by invitation · Phase 4

Clinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical Tretinoin

Ages No minimum to no maximum · 1 site · Colgate Palmolive

NCT07932288 on ClinicalTrials.gov

Recruiting · Phase 3

Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)

Ages 12 Years to no maximum · 35 sites · Sagimet Biosciences Inc.

NCT07863193 on ClinicalTrials.gov

Recruiting · Phase 1 / Phase 2

Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne

Ages 12 Years to 17 Years · 3 sites · Sanofi

NCT07756957 on ClinicalTrials.gov

Recruiting · Not applicable

Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne Vulgaris

Ages 12 Years to 55 Years · 1 site · Pak Emirates Military Hospital

NCT07883538 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Study to Determine Efficacy, Safety, and Tolerability of B244 as a Topical Spray in Subjects With Moderate to Severe Acne Vulgaris

Ages 12 Years to no maximum · 0 sites · AOBiome LLC

NCT07866105 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Demodex Mites in Acne Patients and Herbal Extract Susceptibility

Ages 18 Years to 45 Years · 0 sites · Assiut University

NCT07845149 on ClinicalTrials.gov

Recruiting · Not applicable

Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone Skin

Ages 18 Years to no maximum · 2 sites · WiQo S.p.A.

NCT07866131 on ClinicalTrials.gov

Recruiting · Phase 4

Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate Acne

Ages 18 Years to 40 Years · 1 site · Nishtar Medical University

NCT07915648 on ClinicalTrials.gov

Recruiting · Not applicable

Radiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgaris

Ages 18 Years to 40 Years · 1 site · Jeisys Medical Inc

NCT07805655 on ClinicalTrials.gov

Recruiting · Not applicable

Dermal and Ophthalmological Acceptability and Comedogenicity Assessment of a Cosmetic Product

Ages 18 Years to 45 Years · 1 site · Brainfarma Industria Química e Farmacêutica S/A

NCT07848555 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation

Ages 15 Years to 35 Years · 1 site · Foundation University Islamabad

NCT07539129 on ClinicalTrials.gov

Not yet recruiting · Not applicable

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

Ages 16 Years to no maximum · 0 sites · National University Hospital, Singapore

NCT07481019 on ClinicalTrials.gov

Recruiting · Phase 3

Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

Ages 14 Years to 45 Years · 18 sites · Eurofarma Laboratorios S.A.

NCT06905210 on ClinicalTrials.gov

Not yet recruiting · Early Phase 1

Comparison of Topical Clascoterone and Adapalene for Mild Acne Vulgaris

Ages 12 Years to 35 Years · 0 sites · Khyber Teaching Hospital

NCT07673094 on ClinicalTrials.gov

Recruiting · Not applicable

Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital

Ages 15 Years to 49 Years · 1 site · Sohag University

NCT07822360 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe Acne Vulgaris

Ages 16 Years to no maximum · 0 sites · Università degli Studi di Brescia

NCT07089368 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Clinical Observation of Skin Condition in Patients With Acne Vulgaris Using Ubiquinol, Pomegranate Peel Extract, Ceramide, and Salicylic Acid Emulsion

Ages 18 Years to 40 Years · 0 sites · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

NCT07735169 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne Vulgaris

Ages 18 Years to 45 Years · 1 site · Pakistan Institute of Medical Sciences

NCT07639073 on ClinicalTrials.gov

Not yet recruiting · Not applicable

A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy Adults

Ages 18 Years to 65 Years · 1 site · GenCanna Acquisition Corp

NCT07127523 on ClinicalTrials.gov

Recruiting · Not applicable

Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

Ages 18 Years to no maximum · 1 site · USMARI Research & Innovation Centre

NCT07749469 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Exploring Acne Treatments Through Clinical Research Participation

Ages 18 Years to no maximum · 1 site · Power Life Sciences Inc.

NCT07010458 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Safety and Efficacy Evaluation of the Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars

Ages 18 Years to 65 Years · 4 sites · CLASSYS Inc.

NCT07620769 on ClinicalTrials.gov

Not yet recruiting · Phase 3

1% Clascoterone Cream for the Treatment Acne Vulgaris

Ages 12 Years to no maximum · 0 sites · Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

NCT07457294 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars

Ages 18 Years to 45 Years · 0 sites · Assiut University

NCT07471854 on ClinicalTrials.gov

Recruiting · Not applicable

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

Ages 40 Years to 60 Years · 1 site · King's College London

NCT07341087 on ClinicalTrials.gov

Recruiting · Phase 4

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

Ages 9 Years to no maximum · 1 site · Integrative Skin Science and Research

NCT07544251 on ClinicalTrials.gov

Not yet recruiting · Phase 1 / Phase 2

Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris

Ages 15 Years to 40 Years · 1 site · Yohanes Firmansyah, dr, MH, MM

NCT07504822 on ClinicalTrials.gov

Recruiting · Not applicable

Gut Microbiome Diversity in Adults With Inflammatory and Immune-Mediated Skin Diseases

Ages 18 Years to no maximum · 1 site · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

NCT07944196 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Sebum Metabolomics and Lipidomics for Clinical Applications

Ages 20 Years to no maximum · 0 sites · National Taiwan University Hospital

NCT07549828 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)

Ages 18 Years to no maximum · 0 sites · Assiut University

NCT07421804 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study

Ages 18 Years to 45 Years · 1 site · Assiut University

NCT07473895 on ClinicalTrials.gov

Not yet recruiting · Phase 1 / Phase 2

A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.

Ages 18 Years to no maximum · 1 site · Shanghai Huaota Biopharmaceutical Co., Ltd.

NCT07449156 on ClinicalTrials.gov

Recruiting · Not applicable

Poly-L-Lactic Acid in Atrophic Acne Scars

Ages 18 Years to 40 Years · 1 site · Zagazig University

NCT07523217 on ClinicalTrials.gov

Recruiting · Early Phase 1

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

Ages 12 Years to no maximum · 1 site · Pham Ngoc Thach University of Medicine

NCT07474883 on ClinicalTrials.gov

Recruiting · Phase 4

Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris

Ages 12 Years to 99 Years · 3 sites · IR INNOVATE RESEARCH PRIVATE LIMITED

NCT07918001 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients

Ages 18 Years to 25 Years · 0 sites · National Skin Centre

NCT07411638 on ClinicalTrials.gov

Recruiting · Phase 2

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Ages 12 Years to 17 Years · 28 sites · Incyte Corporation

NCT07213973 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris

Ages 18 Years to 35 Years · 0 sites · Jinnah Postgraduate Medical Centre

NCT07392047 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris

Ages 18 Years to no maximum · 1 site · Kane Biotech Inc

NCT06729450 on ClinicalTrials.gov

Recruiting · Not applicable

The Impact of Baseline Hormonal Profiles (DHEAS, FSH, LH) on Treatment Response to Systemic Isotretinoin in Adult Female Patients With Acne Vulgaris

Ages 18 Years to 40 Years · 1 site · Biruni University

NCT07818525 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study

Ages No minimum to no maximum · 1 site · Venus Research Center

NCT07296523 on ClinicalTrials.gov

Recruiting · Not applicable

Facial Skin Microbiome in Patients With Moderate-to-Severe Acne Vulgaris Treated With Isotretinoin

Ages 16 Years to 35 Years · 1 site · Can Tho University of Medicine and Pharmacy

NCT07834138 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris

Ages 18 Years to 40 Years · 0 sites · Jiangxi Kvvit Pharmaceutical Co., Ltd.

NCT07345390 on ClinicalTrials.gov

Recruiting · Phase 2

Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne

Ages 18 Years to 33 Years · 1 site · Shenzhen People's Hospital

NCT07366229 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS

Ages 18 Years to no maximum · 1 site · Peking Union Medical College

NCT07261072 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Comparative Real-world Study on Ablative Fractional CO₂ Laser vs PRP With Microneedling for Acne Scar Treatment.

Ages 18 Years to no maximum · 1 site · Dr. Sirajul Islam Medical College

NCT07189923 on ClinicalTrials.gov

Recruiting · Not applicable

Acne Face Wash for Reducing the Contamination Rate in Arthroscopic Rotator Cuff Repair Surgery

Ages 18 Years to no maximum · 1 site · National Taiwan University Hospital

NCT07239349 on ClinicalTrials.gov

Enrolling by invitation · Phase 2 / Phase 3

A Split-Face Comparative Study of Mono Threads Versus Combination With Plasma Gel for the Treatment of Post-Acne Scars

Ages 18 Years to no maximum · 1 site · Tanta University

NCT07903012 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Subcision With CO₂ Laser or PRP vs Subcision Alone in Atrophic Acne Scars

Ages 18 Years to no maximum · 1 site · Assiut University

NCT07199608 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Evaluation of Serum Ceramides C16, C24, and Sphingosine-1-Phosphate (S1P) in Patients With Acne Vulgaris

Ages 15 Years to 40 Years · 0 sites · Sohag University

NCT07250880 on ClinicalTrials.gov

Recruiting · Not applicable

PRP Plus Fractional CO₂ Laser for Acne Scars

Ages 18 Years to 40 Years · 1 site · Gujranwala medical college District Headquarters Hospital, Gujranwala

NCT07352215 on ClinicalTrials.gov

Recruiting · Phase 3

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

Ages 22 Years to no maximum · 10 sites · AbbVie

NCT07207369 on ClinicalTrials.gov

Recruiting · Not applicable

Subcision With Injection of Poly Deoxyribonucleotide Versus Subcision With Injection of Non-cross Linked Hyaluronic Acid in Rolling Acne Scars Treatment.

Ages 18 Years to no maximum · 1 site · Cairo University

NCT07547956 on ClinicalTrials.gov

Recruiting · Not applicable

Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars

Ages 18 Years to 45 Years · 1 site · University of Nove de Julho

NCT07151599 on ClinicalTrials.gov

Recruiting · Phase 1

1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)

Ages 18 Years to 60 Years · 1 site · Wynn Medical Center

NCT07155239 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES

Ages 18 Years to 60 Years · 1 site · Dr.dr.Irma Bernadette, SpKK (K)

NCT07121439 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate

Ages 12 Years to 45 Years · 1 site · Sohag University

NCT07062081 on ClinicalTrials.gov

Recruiting · Not applicable

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Ages 18 Years to no maximum · 8 sites · Leiden University Medical Center

NCT07021495 on ClinicalTrials.gov

Recruiting · Not applicable

Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study

Ages 18 Years to 40 Years · 1 site · Shenyang Medical College

NCT07056673 on ClinicalTrials.gov

Recruiting · Phase 1 / Phase 2

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

Ages 18 Years to 45 Years · 4 sites · Sanofi Pasteur, a Sanofi Company

NCT07013747 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Phenytoin in Treatment of Atrophic Post Acne Scars.

Ages 18 Years to no maximum · 0 sites · Assiut University

NCT06942468 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Efficacy of Stromal Vascular Fraction on Acne Scar Correction

Ages 19 Years to 45 Years · 0 sites · Seoul National University Hospital

NCT07094958 on ClinicalTrials.gov

Not yet recruiting · Not applicable

An Observational Clinical Study to Evaluate the Efficacy of the CeraVe Skin Care Line

Ages 13 Years to no maximum · 0 sites · ChinaNorm

NCT07044024 on ClinicalTrials.gov

Recruiting · Not applicable

PMCF Investigation of Medical Device ChitoCare® Medical

Ages No minimum to no maximum · 2 sites · Primex ehf

NCT06850389 on ClinicalTrials.gov

Recruiting · Phase 1

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

Ages 18 Years to 55 Years · 4 sites · Sagimet Biosciences Inc.

NCT06989840 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Dry Eye Disease With Isotretinoin ISOTRETINOIN

Ages 18 Years to 40 Years · 0 sites · Cairo University

NCT06725290 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Excimer Light Versus Blue Light in Acne

Ages 18 Years to 25 Years · 0 sites · Cairo University

NCT06725303 on ClinicalTrials.gov

Recruiting · Early Phase 1

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

Ages 18 Years to 40 Years · 1 site · Shanghai Zhongshan Hospital

NCT07007078 on ClinicalTrials.gov

Not yet recruiting · Phase 2

The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment

Ages 13 Years to 45 Years · 1 site · Universitas Padjadjaran

NCT06925386 on ClinicalTrials.gov

Recruiting · Phase 3

Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients

Ages 13 Years to 30 Years · 19 sites · Centre Hospitalier Universitaire de Nice

NCT06447480 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Comparison of Efficacy of 35% Glycolic Acid vs 20% Salicylic Acid Peel in the Treatment of Post Acne Scars

Ages 18 Years to 45 Years · 1 site · Hayatabad Medical Complex

NCT06943118 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Serum CXCL10 and CRP Levels in Patients With Acne Vulgaris in Correlation With Disease Severity

Ages 12 Years to 40 Years · 1 site · Assiut University

NCT06869109 on ClinicalTrials.gov

Recruiting · Not applicable

Comparison of Efficacy of Microneedling With Platelet Rich Plasma Vs Microneedling With Topical Insulin in the Treatment of Acne Scars

Ages 18 Years to 50 Years · 1 site · Khyber Teaching Hospital

NCT06978361 on ClinicalTrials.gov

Not yet recruiting · Phase 3

The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Salicylic Acid 0,5%, Zinc Lactate, Hyaluronic Acid and Spot Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Honokiol

Ages 15 Years to 50 Years · 1 site · Dr.dr.Irma Bernadette, SpKK (K)

NCT06775314 on ClinicalTrials.gov

Recruiting · Early Phase 1

Weekly Isotretinoin vs Tetracycline for Moderate Acne

Ages 12 Years to no maximum · 1 site · Medical University of South Carolina

NCT06225570 on ClinicalTrials.gov

Not yet recruiting · Not applicable

HS ABSCESSES: I&D VS PUNCH DEBRIDEMENT

Ages 16 Years to no maximum · 1 site · Erasmus Medical Center

NCT06731309 on ClinicalTrials.gov

Recruiting · Not applicable

Assessment of Serum Catestatin Level in Acne Vulgaris Patients

Ages 18 Years to 40 Years · 1 site · Aswan University

NCT07054398 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic Dermatosis

Ages 18 Years to 60 Years · 1 site · Nanjing First Hospital, Nanjing Medical University

NCT06763367 on ClinicalTrials.gov

Recruiting · Not applicable

Global Healthcare Study on Hidradenitis Suppurativa

Ages 14 Years to no maximum · 1 site · Julia Tatjana Maul

NCT07659769 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Various Procedural Treatment Options for Post-acne Atrophic Scars

Ages 13 Years to 50 Years · 1 site · Sheikh Zayed Medical College

NCT06770608 on ClinicalTrials.gov

Recruiting · Early Phase 1

Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%

Ages 18 Years to no maximum · 1 site · Virginia Clinical Research, Inc.

NCT06645821 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Fractional CO2 Laser Delivery of Topical Insulin Versus Platelet Rich Plasma in Treatment of Atrophic Post Acne Scars

Ages 18 Years to 65 Years · 0 sites · Assiut University

NCT06590909 on ClinicalTrials.gov

Recruiting · Not applicable

AVAVA MIRIA General Use

Ages 18 Years to 70 Years · 1 site · AVAVA, Inc.

NCT06868615 on ClinicalTrials.gov

Recruiting · Not applicable

A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase

Ages 14 Years to 24 Years · 1 site · Pierre Fabre Dermo Cosmetique

NCT06716398 on ClinicalTrials.gov

Recruiting · Phase 3

Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris

Ages 12 Years to no maximum · 1 site · Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

NCT06403501 on ClinicalTrials.gov

Recruiting · Phase 1 / Phase 2

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Ages 18 Years to 45 Years · 94 sites · Sanofi Pasteur, a Sanofi Company

NCT06316297 on ClinicalTrials.gov

Recruiting · Not applicable

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Ages 18 Years to no maximum · 1 site · Innovaderm Research Inc.

NCT05994976 on ClinicalTrials.gov

Recruiting · Not applicable

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

Ages 18 Years to no maximum · 1 site · Montefiore Medical Center

NCT05362929 on ClinicalTrials.gov

Recruiting · Not applicable

Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa

Ages No minimum to 80 Years · 1 site · Peking Union Medical College

NCT06926192 on ClinicalTrials.gov

Recruiting · Not applicable

Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

Ages No minimum to no maximum · 1 site · Nantes University Hospital

NCT03465150 on ClinicalTrials.gov

Recruiting · Not applicable

Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars

Ages 18 Years to no maximum · 1 site · Cytrellis Biosystems, Inc.

NCT03782038 on ClinicalTrials.gov

More: Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials · Osteoporosis clinical trials · Rett syndrome clinical trials